Lobectomy vs. Sublobar Resection for Small NSCLC
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two types of lung surgery for early-stage non-small cell lung cancer. You may qualify if you have a small tumor (2 cm or less) with specific features on a CT scan. The goal is to see which surgery offers better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your tumor is 2 cm or smaller on a CT scan, with a specific appearance (consolidation-to-tumor ratio between 0.5 and 1).
- You have good lung function (enough to tolerate either surgery).
- You have no more than 3 lung spots on the same side of the lung.
- You have not had any previous lung surgery or anti-cancer treatment for this cancer.
- You do not have serious heart, lung, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches for advanced lung cancer (stage IIA-IIIB) after patients have already received immunotherapy and chemotherapy. Researchers want to see if removing a smaller portion of the lung (sub-lobectomy) works as well as removing an entire lobe (lobectomy), potentially reducing side effects while fighting cancer.
This trial compares two types of lung surgery for certain small lung cancers in the middle part of the lung: removing a segment (segmentectomy) versus removing a whole lobe (lobectomy). It aims to see which surgery works better while balancing cancer control and lung function.
This study compares two types of surgery for small, early-stage lung cancers that are deep inside the lung. It aims to see if removing only a small part of the lung (segmentectomy) works as well as removing a whole lobe (lobectomy), which may help patients recover faster and preserve more lung function.
This study compares two lung cancer surgeries: segmentectomy (removing only the part of the lung with the tumor) and lobectomy (removing the entire lobe). It is for people with early-stage non-small cell lung cancer that is 2–3 cm and more solid than hazy on a CT scan. The goal is to see which surgery works better while preserving lung function.
This trial tests if a smaller surgery (sublobar resection) works well for patients with very early-stage lung cancer (adenocarcinoma in situ or minimally invasive adenocarcinoma) that is found during the operation. It may help avoid removing more lung tissue than necessary.
This trial compares two lung-surgery options for small lung adenocarcinoma (≤ 2 cm): removing a lung segment versus removing an entire lobe. It aims to see which operation controls the cancer while preserving lung function.
Hear when a new NSCLC, Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.